Our Focus

The economic case for prevention is well established. What holds it back is how health systems budget and pay for care, with spending weighted toward treatment and returns that arrive too far in the future to compete for short-term funding. Closing that gap is as much a financing challenge as a clinical one.

Why the Economics of Prevention Matter

Prevention improves health outcomes and supports the long-term sustainability of health systems. Investment in immunization, early detection, and health education can reduce healthcare costs, improve population health across the life course, and support workforce productivity. Prioritizing prevention is essential to building resilient, efficient systems that can respond to demographic change and rising disease burden.

Why Prevention Stays Underfunded

Despite strong evidence, investment in prevention remains limited and uneven. Health spending stays concentrated on treatment, reflecting short-term budget cycles and fragmented funding, while prevention's long-term returns are rarely fully accounted for in decision-making. Financial incentives and policy frameworks do not consistently support preventive approaches, limiting their integration into health systems.

From Evidence to Implementation

Meeting these challenges requires aligning economic policy, financing mechanisms, and system priorities with prevention. This work spans cost–benefit and cost-effectiveness analysis, economic incentives that support public health interventions, the financial impact of preventable disease on systems and societies, and policy approaches that integrate prevention into national health strategies.

Resources

Insights, Reports & Expert Perspectives

Explore expert briefings and relevant publications

The Economic and Societal Imperative of Lifecourse Prevention

Economic and societal case for lifecourse prevention and the role of vaccination in protecting older adults from infectious diseases.
December 4, 2025

Closing the women’s health gap: The United Kingdom’s £36 billion opportunity

McKinsey Health Institute analysis finds that closing gaps in women's health outcomes could add £36 billion annually to UK GDP by 2040.

July 1, 2026

Primary care, reimagined: Workforce and care model innovation in a modern age

McKinsey and West Health model how underinvestment in US primary care drives avoidable costs and how reform could reduce that burden by 2050.

May 19, 2026

How greater spending on preventive health can promote economic growth

Preventive health spending, especially immunization, carries strong investment value and could help EU states ease budget pressure and boost growth, per WEF.

May 15, 2026

World Population Day: Why healthier populations are key to stronger economies

McKinsey analysis on scaling proven preventive interventions offers the greatest opportunity to reduce years lived in poor health and strengthen economies.

February 16, 2026

Good health is the world’s best investment – and the key to economic resilience

Poor health costs the global economy roughly 15 percent of GDP annually. The World Economic Forum makes the case for prevention as economic infrastructure.

January 29, 2026

Health, Economic Growth and Jobs

The World Bank finds that health investment drives job creation directly and indirectly, with returns of up to $23 for every $1 spent on nutrition.

April 17, 2025

The Longevity Dividend: The Business Case for Linking Health and Wealth

WEF: Three low-cost preventive interventions could save healthcare systems more than $5.8 trillion and unlock $645 billion in productivity gains by 2040.

Focus Zones

Priority Areas Shaping the
Future of Prevention

The initiative focuses on key prevention priorities shaping health systems, policy frameworks, and long-term population outcomes across the LifeCourse.